"Amiodarone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
Descriptor ID |
D000638
|
MeSH Number(s) |
D03.633.100.127.075
|
Concept/Terms |
Cordarone- Cordarone
- Amiodarex
- Trangorex
- Kordaron
- Cordarex
|
Below are MeSH descriptors whose meaning is more general than "Amiodarone".
Below are MeSH descriptors whose meaning is more specific than "Amiodarone".
This graph shows the total number of publications written about "Amiodarone" by people in this website by year, and whether "Amiodarone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 2 | 0 | 2 |
2000 | 1 | 1 | 2 |
2002 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 2 | 0 | 2 |
2005 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2016 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amiodarone" by people in Profiles.
-
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019 07; 29(5):285-295.
-
Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60.
-
Adverse Reactions of Amiodarone on the Thyroid. Cardiology. 2016; 134(3):364-5.
-
Impact of Food and Drug Administration hepatotoxicity warning on prescribing and monitoring of dronedarone in a tertiary teaching hospital. Int J Pharm Pract. 2015 Dec; 23(6):456-60.
-
Ventricular tachycardia associated with radiation-induced cardiac sarcoma. Tex Heart Inst J. 2014 Dec; 41(6):620-5.
-
Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology. 2010 Dec; 151(12):5961-70.
-
New advances and new questions in cardiovascular therapeutics. Am J Ther. 2009 Sep-Oct; 16(5):375-7.
-
Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007 Sep 19; 298(11):1312-22.
-
Letter from Konstantinos P. Letsas et al. - invited editorial comment. Cardiology. 2006; 105(3):148.
-
Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med. 2005 Sep 06; 143(5):327-36.